Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Multimarker Serum Testing Related to Ovarian Cancer, Effective 9/1/2026 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Multimarker Serum Testing Related to Ovarian Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Multicancer Early Detection Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Monitored Anesthesia Care for Gastrointestinal Endoscopic Procedures | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Minimally Invasive Coronary Artery Bypass Graft Surgery | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Mental Illness and Substance Use Disorders Mandate | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Meniscal Allografts and Other Meniscal Implants | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Medicare Advantage Plans National and Local Coverage Determinations | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Medical Necessity | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Measurement of Ocular Blood Flow for Glaucoma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate in the Diagnosis and Management of Respiratory Disorders | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes, Effective 10/1/2026 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Mastectomy Treatment, Breast Reconstruction and Hospital Stays Mandates | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Mass Spectrometry (MS) Testing in Monoclonal Gammopathy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Manipulation Under Anesthesia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Magnetic Capsule Endoscopy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Lysis of Epidural Adhesions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Lyme Disease Diagnosis and Treatment Mandate | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Low-Level Laser Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Laser Treatment of Onychomycosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Laser Interstitial Thermal Therapy for Neurological Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Intravitreal and Punctum Corticosteroid Implants, Effective 10/1/2026 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Intravitreal and Punctum Corticosteroid Implants | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Intraocular Radiotherapy for Age-Related Macular Degeneration | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Intracellular Micronutrient Analysis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Intra-Articular Hyaluronan Injections for Osteoarthritis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Interventions for Progressive Scoliosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Interferential Current Stimulation, Effective 10/1/2026 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Interferential Current Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Ingestible pH and Pressure Capsule | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Ingestible Devices for the Treatment of Constipation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Implantation of Anterior Segment Intraocular Nonbiodegradable Drug-Eluting System | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Implantable Bone Conduction and Bone Anchored Hearing Aids | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Immune Cell Function Assay | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Image Guided Minimally Invasive Spinal Decompression for Spinal Stenosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Hyperbaric Oxygen Therapy (HBO) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Human Leukocyte Antigen (HLA) Testing Mandate | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disorders | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Home Uterine Activity Monitoring | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Home Spirometry | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Home Prothrombin Time Monitoring | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins during Breast-Conserving Surgery | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Genetic Testing for Inherited Thrombophilia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Gene Therapies for Duchenne Muscular Dystrophy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Gene Expression Profile Testing and Circulating Tumor DNA Testing for Predicting Recurrence in Colon Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Gastric Electrical Stimulation - Insertion | New policy |